Guggenheim Maintains Buy on IDEAYA Biosciences, Raises Price Target to $54
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst Paul Jeng maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $50 to $54.
Guggenheim analyst Paul Jeng maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $50 to $54.